Atea Pharmaceuticals Company Insiders

AVIR Stock  USD 2.99  0.07  2.29%   
Atea Pharmaceuticals' insiders are aggressively selling. The analysis of insiders' sentiment of trading Atea Pharmaceuticals stock suggests that virtually all insiders are panicking at this time. Atea Pharmaceuticals employs about 75 people. The company is managed by 13 executives with a total tenure of roughly 175 years, averaging almost 13.0 years of service per executive, having 5.77 employees per reported executive.

Atea Pharmaceuticals' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-12-10Franklin M BergerDisposed 359606 @ 2.85View
2024-09-19Jean-Pierre SommadossiDisposed 1841 @ 4View
2024-09-17Jean-Pierre SommadossiDisposed 33941 @ 4.05View
2024-06-20Bruce PolskyDisposed 17544 @ 3.49View
2024-06-05Jean-Pierre SommadossiDisposed 1006 @ 4View
2024-02-01Wayne FosterDisposed 12477 @ 3.84View
Monitoring Atea Pharmaceuticals' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atea Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Atea Stock, please use our How to Invest in Atea Pharmaceuticals guide.

Atea Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.1425) % which means that it has lost $0.1425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3346) %, meaning that it created substantial loss on money invested by shareholders. Atea Pharmaceuticals' management efficiency ratios could be used to measure how well Atea Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 02/02/2025, Return On Tangible Assets is likely to drop to -0.22. In addition to that, Return On Capital Employed is likely to drop to -0.28. At this time, Atea Pharmaceuticals' Non Current Assets Total are relatively stable compared to the past year. As of 02/02/2025, Non Currrent Assets Other is likely to grow to about 1.7 M, while Net Tangible Assets are likely to drop slightly above 398.8 M.
As of 02/02/2025, Common Stock Shares Outstanding is likely to drop to about 85.7 M. In addition to that, Net Loss is likely to grow to about (99.1 M)

Atea Pharmaceuticals Workforce Comparison

Atea Pharmaceuticals is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 338. Atea Pharmaceuticals totals roughly 75.0 in number of employees claiming about 22% of equities under Health Care industry.

Atea Pharmaceuticals Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Atea Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Atea Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Atea Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
1.0
2
2
 25,000 
 25,000 
2024-06-01
2.25
18
8
 623,700 
 217,450 
2024-03-01
1.0
12
12
 1,691,736 
 499,784 
2020-12-01
0.3443
21
61
 16,446,374 
 18,528,149 

Atea Pharmaceuticals Notable Stakeholders

An Atea Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Atea Pharmaceuticals often face trade-offs trying to please all of them. Atea Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Atea Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Andrea JDExecutive CFOProfile
CPA CPAExec OfficerProfile
XiaoJian ZhouExecutive DevelopmentProfile
Jayanthi WolfExecutive AffairsProfile
Wayne CPAExecutive OfficerProfile
Ariyapadi KrishnarajVice MarketingProfile
JeanPierre SommadossiChairman, FounderProfile
John VavrickaChief OfficerProfile
Nancy AgrawalExecutive DevelopmentProfile
Maria MDChief OfficerProfile
Jonae BarnesSenior CommunicationsProfile
Keith PietropaoloSenior SciencesProfile
Adel MoussaExecutive ChemistryProfile

About Atea Pharmaceuticals Management Performance

The success or failure of an entity such as Atea Pharmaceuticals often depends on how effective the management is. Atea Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Atea management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Atea management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.21)(0.22)
Return On Capital Employed(0.26)(0.28)
Return On Assets(0.21)(0.22)
Return On Equity(0.28)(0.27)

Atea Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Atea Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Atea Pharmaceuticals within its industry.

Atea Pharmaceuticals Manpower Efficiency

Return on Atea Pharmaceuticals Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.8M
Net Loss Per Executive10.5M
Working Capital Per Employee7.4M
Working Capital Per Executive42.9M

Additional Tools for Atea Stock Analysis

When running Atea Pharmaceuticals' price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.